Home NDC 68083-501 edaravone
Product NDC 68083-501
11-digit product format 680830501
Labeler code 68083
Product ID 68083-501_57566e6e-e90a-4fdf-b23c-d8af19893fd2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name edaravone
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Gland Pharma Limited
Application ANDA216199
Marketing category ANDA
Marketing start 2024-05-06
Substance EDARAVONE
Active strength 60 mg/100mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A216199-001 EDARAVONE EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RS 2024-05-06 A216199-002 EDARAVONE EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS 2024-05-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A216199-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RS 2024-05-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS 2024-05-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RS 2024-05-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RS 2024-05-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS AP 2024-05-06 8072bd15b7f6…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216199-001 EDARAVONE 30MG/100ML (0.3MG/ML) SOLUTION / INTRAVENOUS AP RS 2024-05-06 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A216199-002 EDARAVONE 60MG/100ML (0.6MG/ML) SOLUTION / INTRAVENOUS 2024-05-06 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base edaravone
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength EDARAVONE 60 mg/100mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination S798V6YJRP Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1924316 Internal RxNorm lookup 2681044 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68083-501-01 edaravone 1 in 1 CARTON INJECTION, SOLUTION 1 4 68083-501-01 edaravone 1 in 1 POUCH INJECTION, SOLUTION 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68083-501 EDARAVONE INJECTION, SOLUTION [GLAND PHARMA LIMITED] 4 Current NDC, 2 package rows 20240509_46452eb5-db17-400d-b25b-11844a11e711.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 68083-501-01 68083050101 1 POUCH in 1 CARTON (68083-501-01) / 1 BAG in 1 POUCH / 100 mL in 1 BAG 1 pouch 2024-05-06 No No Current